Literature DB >> 9822613

Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line.

H Wang1, P Maechler, K A Hagenfeldt, C B Wollheim.   

Abstract

Mutations in the hepatocyte nuclear factor-1alpha (HNF-1alpha) have been linked to subtype 3 of maturity-onset diabetes of the young (MODY3), which is characterized by a primary defect in insulin secretion. The role of HNF-1alpha in the regulation of pancreatic beta-cell function was investigated. Gene manipulation allowed graded overexpression of HNF-1alpha and controlled dominant-negative suppression of HNF-1alpha function in insulinoma INS-1 cells. We show that HNF-1alpha is essential for insulin gene transcription, as demonstrated by a pronounced decrease in insulin mRNA expression and in insulin promoter activity under dominant-negative conditions. The expression of genes involved in glucose transport and metabolism including glucose transporter-2 and L-type pyruvate kinase is also regulated by HNF-1alpha. Loss of HNF-1alpha function leads to severe defects in insulin secretory responses to glucose and leucine, resulting from impaired glucose utilization and mitochondrial oxidation. The nutrient-evoked ATP production and subsequent changes in plasma membrane potential and intracellular Ca2+ were diminished by suppression of HNF-1alpha function. These results suggest that HNF-1alpha function is essential for maintaining insulin storage and nutrient-evoked release. The defective mitochondrial oxidation of metabolic substrates causes impaired insulin secretion, indicating a molecular basis for the diabetic phenotype of MODY3 patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822613      PMCID: PMC1171015          DOI: 10.1093/emboj/17.22.6701

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243.

Authors:  T Kobayashi; K Nakanishi; H Nakase; H Kajio; M Okubo; T Murase; K Kosaka
Journal:  Diabetes       Date:  1997-10       Impact factor: 9.461

2.  Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction.

Authors:  H Nishigori; S Yamada; T Kohama; H Tomura; K Sho; Y Horikawa; G I Bell; T Takeuchi; J Takeda
Journal:  Diabetes       Date:  1998-08       Impact factor: 9.461

3.  A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1.

Authors:  A Nicosia; P Monaci; L Tomei; R De Francesco; M Nuzzo; H Stunnenberg; R Cortese
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

4.  The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain.

Authors:  M Frain; G Swart; P Monaci; A Nicosia; S Stämpfli; R Frank; R Cortese
Journal:  Cell       Date:  1989-10-06       Impact factor: 41.582

5.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

6.  Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.

Authors:  M Pontoglio; S Sreenan; M Roe; W Pugh; D Ostrega; A Doyen; A J Pick; A Baldwin; G Velho; P Froguel; M Levisetti; S Bonner-Weir; G I Bell; M Yaniv; K S Polonsky
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

7.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Effect of 5'-flanking sequence deletions on expression of the human insulin gene in transgenic mice.

Authors:  M Fromont-Racine; D Bucchini; O Madsen; P Desbois; S Linde; J H Nielsen; C Saulnier; M A Ripoche; J Jami; R Pictet
Journal:  Mol Endocrinol       Date:  1990-05

9.  vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1.

Authors:  J Rey-Campos; T Chouard; M Yaniv; S Cereghini
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  LFB3, a heterodimer-forming homeoprotein of the LFB1 family, is expressed in specialized epithelia.

Authors:  V De Simone; L De Magistris; D Lazzaro; J Gerstner; P Monaci; A Nicosia; R Cortese
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more
  40 in total

Review 1.  Transcriptional networks controlling pancreatic development and beta cell function.

Authors:  J M Servitja; J Ferrer
Journal:  Diabetologia       Date:  2004-04       Impact factor: 10.122

2.  A transcription factor regulatory circuit in differentiated pancreatic cells.

Authors:  S F Boj; M Parrizas; M A Maestro; J Ferrer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Neuronatin, a downstream target of BETA2/NeuroD1 in the pancreas, is involved in glucose-mediated insulin secretion.

Authors:  Khoi Chu; Ming-Jer Tsai
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

4.  MAFA controls genes implicated in insulin biosynthesis and secretion.

Authors:  H Wang; T Brun; K Kataoka; A J Sharma; C B Wollheim
Journal:  Diabetologia       Date:  2006-12-06       Impact factor: 10.122

5.  Differential effects of HNF-1α mutations associated with familial young-onset diabetes on target gene regulation.

Authors:  Maria Galán; Carmen-Maria García-Herrero; Sharona Azriel; Manuel Gargallo; Maria Durán; Juan-Jose Gorgojo; Victor-Manuel Andía; Maria-Angeles Navas
Journal:  Mol Med       Date:  2010-12-15       Impact factor: 6.354

6.  The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion.

Authors:  Rana K Gupta; Marko Z Vatamaniuk; Catherine S Lee; Reed C Flaschen; James T Fulmer; Franz M Matschinsky; Stephen A Duncan; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

7.  Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells.

Authors:  H Wang; M Iezzi; S Theander; P A Antinozzi; B R Gauthier; P A Halban; C B Wollheim
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

8.  INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells.

Authors:  Caroline Bonner; Siobhán Bacon; Caoimhín G Concannon; Syed R Rizvi; Mathurin Baquié; Angela M Farrelly; Seán M Kilbride; Heiko Dussmann; Manus W Ward; Chantal M Boulanger; Claes B Wollheim; Rolf Graf; Maria M Byrne; Jochen H M Prehn
Journal:  Diabetes       Date:  2010-08-03       Impact factor: 9.461

9.  Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver.

Authors:  Joan-Marc Servitja; Miguel Pignatelli; Miguel Angel Maestro; Carina Cardalda; Sylvia F Boj; Juanjo Lozano; Enrique Blanco; Amàlia Lafuente; Mark I McCarthy; Lauro Sumoy; Roderic Guigó; Jorge Ferrer
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

10.  Identification of circulating microRNAs in HNF1A-MODY carriers.

Authors:  C Bonner; K C Nyhan; S Bacon; M P Kyithar; J Schmid; C G Concannon; I M Bray; R L Stallings; J H M Prehn; M M Byrne
Journal:  Diabetologia       Date:  2013-05-15       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.